Compare Nomura Holdings Inc (NMR) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nomura Holdings Inc vs Health Care Select Sector SPDR Fund — how do they compare? Nomura Holdings Inc trades at $10.82 (market cap $31.31B), while Health Care Select Sector SPDR Fund trades at $167.05. The key difference: Nomura Holdings Inc pays a 3.05% dividend while Health Care Select Sector SPDR Fund pays none, and Nomura Holdings Inc is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| NMR | XLV | |
|---|---|---|
Market Cap | $31.31B | — |
Sector | Financials | — |
52-Week High | $10.65 | $175.68 |
52-Week Low | $6.73 | $134.13 |
Dividend Yield | 3.05% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nomura Holdings (NMR) trades at $10.63, showing a slight 0.19% decline. The stock exhibits bullish technical signals with strong moving averages, though RSI levels suggest overbought conditions. Revenue surged to $1.66 trillion in 2025, with net income reaching $340.74 billion and a robust 20.4% margin. Recent earnings beat expectations in Q2 2026, but missed in prior quarters. Analyst sentiment is mixed with a 'Hold' consensus, while news highlights momentum in wholesale and wealth management segments.
Outlook remains cautiously optimistic due to solid profitability and growth, but risks include volatile cash flows, high debt levels, and competitive pressures. The stock's valuation at a P/E of 12.46 appears reasonable, yet investor caution is warranted given earnings inconsistencies and macroeconomic uncertainties affecting financial stocks.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and steady institutional interest, though recent options activity shows increased put volume. Healthcare sector momentum remains supported by strong earnings and defensive positioning in volatile markets.
Outlook remains cautiously optimistic given healthcare's defensive characteristics and potential Fed rate hike benefits, though near-term technical weakness and sector-specific headwinds like drug trial failures present risks. The ETF's low expense ratio and diversification across 60 healthcare stocks provide stability for long-term investors seeking sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
